XTRA:EVKChemicals
Evonik Industries (XTRA:EVK) Valuation Check As NOFLU mRNA Flu Vaccine Role Comes Into Focus
Evonik Industries (XTRA:EVK) is back in focus after its role in NOFLU, a European vaccine consortium that just secured an initial €13 million from the European Health and Digital Executive Agency for mRNA flu vaccine development.
See our latest analysis for Evonik Industries.
The NOFLU announcement lands as Evonik Industries’ share price, currently at €13.88, shows mixed momentum, with a recent 7 day share price return of 2.81% but a 1 year total shareholder return decline of 29.84%, pointing...